Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

Doctors battling a rare strain of Ebola in central Africa will probably need to wait many months for a vaccine to be ready ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

HDT Bio, a clinical-stage biotechnology company based in Seattle, Washington, today announced that it received the Medical CBRN Defense Consortium (MCDC) Innovation Prototype Award. The award ...

A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other similar research efforts are also in the very early stages.

The Food and Drug Administration’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory processes. The first sign of trouble was the ...

Shionogi & Co. looks set to put its COVID-19 vaccine into practical use by the end of March 2022 following a government ...

Until May, the Duke Consortia for HIV/AIDS Vaccine Development (CHAVD) had conducted its groundbreaking research with federal funding. Then the National Institutes of Health terminated the program, ...

ETHealthworld.com brings latest vaccine development news, views and updates from all top sources for the Indian Health industry.

BUFFALO, N.Y. — A vaccine under development at the University at Buffalo has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work, detailed in ...